Jeff Aronson

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi request reprint Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore
    Manfred Hauben
    Risk Management Strategy, Pfizer Inc, New York, NY 10017, USA
    Drug Saf 30:645-55. 2007
  2. pmc What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists
    Jeffrey K Aronson
    British Pharmacological Society Green Templeton College, Woodstock Road, Oxford OX2 6HG, UK
    Br J Clin Pharmacol 73:161-9. 2012
  3. doi request reprint Evaluation of pharmacological evidence for forensic purposes
    Jeffrey K Aronson
    University Department of Primary Health Care, Oxford, UK
    Int J Risk Saf Med 24:3-12. 2012
  4. doi request reprint From prescription-only to over-the-counter medicines ('PoM to P'): time for an intermediate category
    Jeffrey K Aronson
    Department of Primary Health Care, University of Oxford, Headington, Oxford OX3 7LF, UK
    Br Med Bull 90:63-9. 2009
  5. ncbi request reprint Clarification of terminology in drug safety
    Jeffrey K Aronson
    Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, UK
    Drug Saf 28:851-70. 2005
  6. ncbi request reprint Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions
    Jeffrey K Aronson
    Reader in Clinical Pharmacology, University Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    J Eval Clin Pract 11:195-208. 2005
  7. pmc Open access publishing: too much oxygen?
    Jeffrey K Aronson
    Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE
    BMJ 330:759. 2005
  8. doi request reprint A strategy for regulatory action when new adverse effects of a licensed product emerge
    Jeffrey K Aronson
    University Department of Primary Health Care, Headington, Oxford, UK
    Drug Saf 32:91-8. 2009
  9. pmc Concentration-effect and dose-response relations in clinical pharmacology
    Jeffrey K Aronson
    University Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    Br J Clin Pharmacol 63:255-7. 2007
  10. pmc Medication errors: definitions and classification
    Jeffrey K Aronson
    Department of Primary Health Care, Oxford, UK
    Br J Clin Pharmacol 67:599-604. 2009

Collaborators

Detail Information

Publications43

  1. ncbi request reprint Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore
    Manfred Hauben
    Risk Management Strategy, Pfizer Inc, New York, NY 10017, USA
    Drug Saf 30:645-55. 2007
    ..In this article, we discuss the implications of these definitive ('between-the-eyes') adverse effects for pharmacovigilance...
  2. pmc What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists
    Jeffrey K Aronson
    British Pharmacological Society Green Templeton College, Woodstock Road, Oxford OX2 6HG, UK
    Br J Clin Pharmacol 73:161-9. 2012
    ..Many trainees therefore leave the discipline when they become consultants...
  3. doi request reprint Evaluation of pharmacological evidence for forensic purposes
    Jeffrey K Aronson
    University Department of Primary Health Care, Oxford, UK
    Int J Risk Saf Med 24:3-12. 2012
    ..Reports should be written in clear English and should not contain statements that rely on expertise that the expert does not possess...
  4. doi request reprint From prescription-only to over-the-counter medicines ('PoM to P'): time for an intermediate category
    Jeffrey K Aronson
    Department of Primary Health Care, University of Oxford, Headington, Oxford OX3 7LF, UK
    Br Med Bull 90:63-9. 2009
    ....
  5. ncbi request reprint Clarification of terminology in drug safety
    Jeffrey K Aronson
    Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, UK
    Drug Saf 28:851-70. 2005
    ..We hope that these definitions will lead to discussion that will allow a corpus of satisfactory definitions to be widely agreed...
  6. ncbi request reprint Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions
    Jeffrey K Aronson
    Reader in Clinical Pharmacology, University Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    J Eval Clin Pract 11:195-208. 2005
    ..One form of pattern recognition, teleoanalysis of data, should, when possible, include not only randomized controlled trials and observational studies, but also case series and anecdotal reports...
  7. pmc Open access publishing: too much oxygen?
    Jeffrey K Aronson
    Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE
    BMJ 330:759. 2005
  8. doi request reprint A strategy for regulatory action when new adverse effects of a licensed product emerge
    Jeffrey K Aronson
    University Department of Primary Health Care, Headington, Oxford, UK
    Drug Saf 32:91-8. 2009
    ..Our proposed framework could also be useful in risk management planning during drug development...
  9. pmc Concentration-effect and dose-response relations in clinical pharmacology
    Jeffrey K Aronson
    University Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    Br J Clin Pharmacol 63:255-7. 2007
  10. pmc Medication errors: definitions and classification
    Jeffrey K Aronson
    Department of Primary Health Care, Oxford, UK
    Br J Clin Pharmacol 67:599-604. 2009
    ..6. Medication errors can be classified, invoking psychological theory, as knowledge-based mistakes, rule-based mistakes, action-based slips, and memory-based lapses. This classification informs preventive strategies...
  11. pmc A manifesto for clinical pharmacology from principles to practice
    Jeffrey K Aronson
    University Department of Primary Health Care, Rosemary Rue Building, Old Road Campus, Headington, Oxford OX3 7LF, UK
    Br J Clin Pharmacol 70:3-13. 2010
    ....
  12. pmc Signs of love, not a love potion
    Jeff Aronson
    University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE
    BMJ 327:1471-2. 2003
  13. pmc Joining the DoTS: new approach to classifying adverse drug reactions
    J K Aronson
    University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, UK
    BMJ 327:1222-5. 2003
  14. doi request reprint Medication errors: what they are, how they happen, and how to avoid them
    J K Aronson
    Department of Primary Health Care, Rosemary Rue Building, Old Road Campus, Headington, Oxford OX3 7LF, UK
    QJM 102:513-21. 2009
    ..In balanced prescribing the mechanism of action of the drug should be married to the pathophysiology of the disease...
  15. doi request reprint Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions
    Jeffrey K Aronson
    University of Oxford, Department of Primary Health Care, Oxford, UK
    Drug Saf 33:995-1002. 2010
    ..Furthermore, when the reliability of these definitions has been examined they have been found to be imperfect...
  16. ncbi request reprint Adverse drug reactions: keeping up to date
    Jeffrey K Aronson
    University Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    Fundam Clin Pharmacol 16:49-56. 2002
    ..Systematic reviews are too few in number (only 1.25% of publications on adverse drug reactions cited in Side Effects of Drugs Annual); more are needed...
  17. pmc Adverse drug reactions--no farewell to harms
    Jeffrey K Aronson
    University Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    Br J Clin Pharmacol 63:131-5. 2007
  18. pmc Anecdotes that provide definitive evidence
    Jeffrey K Aronson
    Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford University, Oxford OX2 6HE
    BMJ 333:1267-9. 2006
  19. ncbi request reprint Identification of system y+L as the high-affinity transporter for L-arginine in human platelets: up-regulation of L-arginine influx in uraemia
    A C Mendes Ribeiro
    University Laboratory of Physiology, Oxford, U K
    Pflugers Arch 438:573-5. 1999
    ....
  20. pmc Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
    S Derry
    Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, Oxford, OX2 6HE, United Kingdom
    BMC Med Res Methodol 1:7. 2001
    ..We have determined how often automated search methods, using indexing terms and/or textwords in the title or abstract, would fail to retrieve trials with adverse effects data...
  21. pmc Nurse prescribers & reporters
    J K Aronson
    University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, UK
    Br J Clin Pharmacol 56:585-7. 2003
  22. ncbi request reprint Clarification of terminology in medication errors: definitions and classification
    Robin E Ferner
    West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK
    Drug Saf 29:1011-22. 2006
    ..Classification of medication errors is important because the probabilities of errors of different classes are different, as are the potential remedies...
  23. ncbi request reprint Disco dancing
    Jeffrey K Aronson
    University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, UK
    Cytopathology 13:326-7. 2002
  24. pmc A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone
    Yoon K Loke
    Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE, UK
    Br J Clin Pharmacol 57:616-21. 2004
    ....
  25. ncbi request reprint Medication errors resulting from the confusion of drug names
    Jeffrey K Aronson
    Expert Opin Drug Saf 3:167-72. 2004
    ..At all times there should be good communication among those who prescribe, supply, and administer medicines, and those who take them...
  26. ncbi request reprint Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm
    Jeffrey K Aronson
    Oxford Radcliffe Hospitals Trust
    Clin Med 5:16-9. 2005
  27. pmc The diagnosis of art: Rachmaninov's hand span
    Manoj Ramachandran
    Royal National Orthopaedic Hospital, Stanmore, Middlesex, UK
    J R Soc Med 99:529-30. 2006
  28. ncbi request reprint Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions
    Jeffrey K Aronson
    Drug Saf 31:355-6; author reply 356-7. 2008
  29. pmc Observational evidence for determining drug safety: Too high a pedestal
    Jeffrey K Aronson
    BMJ 336:735. 2008
  30. pmc The road to health care
    Luis Gabriel Cuervo
    BMJ 329:1-2. 2004
  31. pmc "Open-access" publishing: first the evidence--then the verdict
    Jeffrey K Aronson
    J R Soc Med 99:103-4. 2006
  32. pmc Anecdotes as evidence
    Jeffrey K Aronson
    BMJ 326:1346. 2003
  33. pmc Case reports of suspected adverse drug reactions--systematic literature survey of follow-up
    Yoon Kong Loke
    School of Medicine, Health Policy, and Practice, University of East Anglia, Norwich NR4 7TJ
    BMJ 332:335-9. 2006
    ..To determine whether anecdotal reports of suspected adverse drug reactions are valuable early warning signals...
  34. pmc The diagnosis of art: Caravaggio's jaundiced Bacchus
    Jeffrey K Aronson
    Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    J R Soc Med 100:429-30. 2007
  35. pmc Editors' review of 2006 and the BJCP prize
    Jeffrey K Aronson
    Br J Clin Pharmacol 63:1-4. 2007
  36. pmc The diagnosis of art: exophthalmos--Gustave Doré's ogre
    Jeffrey K Aronson
    Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, UK
    J R Soc Med 99:421. 2006
  37. pmc The diagnosis of art: arthrogryposis and Ribera's The Clubfoot
    Manoj Ramachandran
    Paediatric and Young Adult Orthopaedic Fellow, Royal National Orthopaedic Hospital, Stanmore, Middlesex, UK
    J R Soc Med 99:321-2. 2006
  38. ncbi request reprint Give a drug a good name
    Dinesh K Mehta
    Royal Pharmaceutical Society of Great Britain, London SE1 7JN, UK
    Lancet 369:1326-8. 2007
  39. pmc Drug therapy in kidney disease
    Jeffrey K Aronson
    Br J Clin Pharmacol 63:509-11. 2007
  40. pmc The diagnosis of art: Valentin le désossé and Ehlers-Danlos syndrome
    Jeffrey K Aronson
    Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    J R Soc Med 100:193-4. 2007
  41. pmc Glomerular filtration rate: eGFR in changing drug regimens
    Jeffrey K Aronson
    BMJ 334:1287. 2007
  42. pmc The diagnosis of art: Achilles Emperaire and spondyloepiphyseal dysplasia congenita
    Manoj Ramachandran
    Department of Trauma and Orthopaedics, Barts and The London NHS Trust, UK
    J R Soc Med 100:384-5. 2007
  43. ncbi request reprint Something new every day: defining innovation and innovativeness in drug therapy
    Jeffrey K Aronson
    Department of Primary Health Care, University of Oxford, Headington, Oxford, United Kingdom clinpharm ox ac uk
    J Ambul Care Manage 31:65-8. 2008
    ....